Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Opinion and Evidence in Cancer

Opinion and Evidence in Cancer Am J Cancer 2003; 2 (4): 295-304 FROM THE WORLD LITERATURE 1175-6357/03/0004-0295/$30.00/0 © Adis Data Information BV 2003. All rights reserved. Contents Abstract ............................................................................................................... 295 1. Some Women With a First Diagnosis of Epithelial Ovarian Cancer Do Not Receive Optimal Treatment ..................... 296 2. Dose-Intensified Chemotherapy in Breast Cancer Not Worthwhile ...................................................... 296 3. Continuous Combined Hormone Replacement Therapy Increases Breast Cancer Risk .................................... 296 4. Combination Chemotherapy Regimen Beneficial in Acute Myeloid Leukemia ........................................... 296 5. Oblimersen Is a Promising Adjuvant to Chemotherapy in the Treatment of Multiple Myeloma .............................. 297 6. UK National Institute for Clinical Excellence (NICE) Releases Guidance on Breast, Colorectal Cancer Therapy .............. 297 7. Imatinib Mesylate Shows Promise in the Treatment of HIV-Associated Kaposi’s Sarcoma ................................... 297 8. ABI 007 Shows Antitumor Activity in Women With Breast Cancer Resistant to Taxane Therapy .............................. 297 9. Nolatrexed Shows Promising Antitumor Activity in Patients With Advanced Pancreatic Cancer ............................ 298 10. Polyglutamate Paclitaxel Conjugate is Promising for the Treatment of Non-Small-Cell Lung Cancer and Colorectal Cancer 298 11. XL 119 Has Demonstrated Encouraging Survival Results in Patients With Biliary Cancer ..................................... 298 12. BNP 1350 Shows Antitumor Activity in Patients With Refractory or Relapsed Non-Small-Cell http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Opinion and Evidence in Cancer

American Journal of Cancer , Volume 2 (4) – Aug 10, 2012

Loading next page...
 
/lp/springer-journals/opinion-and-evidence-in-cancer-n6GhWFrL6Q
Publisher
Springer Journals
Copyright
Copyright © 2003 by Adis Data Information BV
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200302040-00008
Publisher site
See Article on Publisher Site

Abstract

Am J Cancer 2003; 2 (4): 295-304 FROM THE WORLD LITERATURE 1175-6357/03/0004-0295/$30.00/0 © Adis Data Information BV 2003. All rights reserved. Contents Abstract ............................................................................................................... 295 1. Some Women With a First Diagnosis of Epithelial Ovarian Cancer Do Not Receive Optimal Treatment ..................... 296 2. Dose-Intensified Chemotherapy in Breast Cancer Not Worthwhile ...................................................... 296 3. Continuous Combined Hormone Replacement Therapy Increases Breast Cancer Risk .................................... 296 4. Combination Chemotherapy Regimen Beneficial in Acute Myeloid Leukemia ........................................... 296 5. Oblimersen Is a Promising Adjuvant to Chemotherapy in the Treatment of Multiple Myeloma .............................. 297 6. UK National Institute for Clinical Excellence (NICE) Releases Guidance on Breast, Colorectal Cancer Therapy .............. 297 7. Imatinib Mesylate Shows Promise in the Treatment of HIV-Associated Kaposi’s Sarcoma ................................... 297 8. ABI 007 Shows Antitumor Activity in Women With Breast Cancer Resistant to Taxane Therapy .............................. 297 9. Nolatrexed Shows Promising Antitumor Activity in Patients With Advanced Pancreatic Cancer ............................ 298 10. Polyglutamate Paclitaxel Conjugate is Promising for the Treatment of Non-Small-Cell Lung Cancer and Colorectal Cancer 298 11. XL 119 Has Demonstrated Encouraging Survival Results in Patients With Biliary Cancer ..................................... 298 12. BNP 1350 Shows Antitumor Activity in Patients With Refractory or Relapsed Non-Small-Cell

Journal

American Journal of CancerSpringer Journals

Published: Aug 10, 2012

There are no references for this article.